This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (538) Web-based and Mobile Health Interventions (3297) Depression and Mood Disorders; Suicide Prevention (1363) Digital Mental Health Interventions, e-Mental Health and Cyberpsychology (1514)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/48740, first published .
Assessing the Efficacy and Safety of a Digital Therapeutic for Symptoms of Depression in Adolescents: Protocol for a Randomized Controlled Trial

Assessing the Efficacy and Safety of a Digital Therapeutic for Symptoms of Depression in Adolescents: Protocol for a Randomized Controlled Trial

Assessing the Efficacy and Safety of a Digital Therapeutic for Symptoms of Depression in Adolescents: Protocol for a Randomized Controlled Trial

Authors of this article:

Daniella J Furman1, 2 Author Orcid Image ;   Shana A Hall1, 2 Author Orcid Image ;   Claudia Avina1 Author Orcid Image ;   Vera N Kulikov1 Author Orcid Image ;   Jessica I Lake1, 2 Author Orcid Image ;   Aarthi Padmanabhan1, 2 Author Orcid Image
Article Authors Cited by Tweetations (3) Metrics

Daniella J Furman   1, 2 , PhD ;   Shana A Hall   1, 2 , PhD ;   Claudia Avina   1 , PhD ;   Vera N Kulikov   1 , BA ;   Jessica I Lake   1, 2 , PhD ;   Aarthi Padmanabhan   1, 2 , PhD

1 Limbix Health, Inc, San Francisco, CA, United States

2 Big Health, Inc, San Francisco, CA, United States

Corresponding Author: